NORMAL CONTROL 1

SECTION 2: Hazards identification

WHMIS 2015 Classification of the substance or mixture

Other hazards which do not result in classification

None. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. 2.5. Unknown acute toxicity No additional information available

2.1 Classification of the substance or mixture

amendment and adjustments Not classified 2.2. Label elements Labelling according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015) and their subsequent amendments and adjustments No labelling applicable 2.3. Hazards associated with known or reasonably anticipated uses No additional information available 2.4. Hazards not otherwise classified Other hazards which do not result in classification : None. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. 2.5. Unknown acute toxicity No additional information available SECTION 3 Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments : Composition: powder containing organic components, human plasma. Comments : The mixture does not contain substances listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA. See Section 11 and 15 This mixture does not contain any substances to be mentioned according to the criteria for section 3.2 of HCS SECTION 4 First-aid measures 4.1. Description of necessary first-aid measures First-aid measures after inhalation : If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. First-aid measures after skin contact : Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if adverse symptoms appear. First-aid measures after eye contact : Wash immediately with plenty of water or normal saline for at least 15 minutes. Keep eyelid open with the finger. Get medical advice if adverse symptoms appear. First-aid measures after ingestion : If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting. Get medical advice if adverse symptoms appear. 4.2. Most important symptoms/effects, acute and delayed Potential adverse human health effects and : The health effects of the product have not been thoroughly investigated. symptoms Symptoms/effects : Acute symptoms and effects are not known.